- Home
- IZM vs COEP Comparison
IZM vs COEP Comparison
Compare IZM & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- COEP
- Stock Information
- Founded
- IZM 2011
- COEP 2017
- Country
- IZM China
- COEP United States
- Employees
- IZM N/A
- COEP 7
- Industry
- IZM Consumer Electronics/Video Chains
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IZM Consumer Discretionary
- COEP Health Care
- Exchange
- IZM Nasdaq
- COEP Nasdaq
- Market Cap
- IZM 23.7M
- COEP 22.3M
- IPO Year
- IZM 2023
- COEP N/A
- Fundamental
- Price
- IZM $1.47
- COEP $9.27
- Analyst Decision
- IZM
- COEP
- Analyst Count
- IZM 0
- COEP 0
- Target Price
- IZM N/A
- COEP N/A
- AVG Volume (30 Days)
- IZM 71.6K
- COEP 1.0M
- Earning Date
- IZM 01-29-2025
- COEP 11-13-2024
- Dividend Yield
- IZM N/A
- COEP N/A
- EPS Growth
- IZM N/A
- COEP N/A
- EPS
- IZM N/A
- COEP N/A
- Revenue
- IZM $177,933,890.00
- COEP N/A
- Revenue This Year
- IZM N/A
- COEP N/A
- Revenue Next Year
- IZM N/A
- COEP N/A
- P/E Ratio
- IZM N/A
- COEP N/A
- Revenue Growth
- IZM N/A
- COEP N/A
- 52 Week Low
- IZM $1.44
- COEP $2.31
- 52 Week High
- IZM $52.21
- COEP $13.58
- Technical
- Relative Strength Index (RSI)
- IZM 17.87
- COEP 75.88
- Support Level
- IZM $1.50
- COEP $6.22
- Resistance Level
- IZM $1.80
- COEP $10.00
- Average True Range (ATR)
- IZM 0.10
- COEP 1.79
- MACD
- IZM -0.02
- COEP 0.43
- Stochastic Oscillator
- IZM 6.59
- COEP 90.51
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.